Wegovy is a glucagon-like peptide-1 (GLP-1) receptor agonist manufactured by Novo Nordisk that is approved by the U.S. Food and Drug Administration (FDA) for weight loss in certain people. It’s ...
The death of a woman who visited a Bronx lifestyle center for a popular anti-aging injection is raising questions about the ...
MannKind announced the FDA approved an at-home furosemide self-injection for treatment of edema in adults with HF or chronic ...
Joseph Mikhael, MD, MEd, highlights the clinical and logistical advantages of the novel on-body injector developed for the ...
July 10 (Reuters) - The U.S. Food and Drug Administration said on Friday it has approved Sanofi's blood cancer drug, Sarclisa, which can be given under the skin through a wearable injector, offering ...
SurvivorNet on MSN
A simpler delivery system: FDA approves subcutaneous injection version of powerful targeted drug isatuximab for multiple myeloma
A new under‑the‑skin version of isatuximab is now approved, giving multiple myeloma patients a much faster and more ...
Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector Sarclisa Escena administered via the CirCLIQ ® on-body injector (OBI) offers a ...
The U.S. Food and Drug Administration (FDA) on Friday approved Sanofi SA’s SNY subcutaneous Sarclisa Escena (isatuximab-irfc) in combination with standard-of-care regimens for multiple myeloma across ...
Browse the complete list of all our published health and social care guidance, including guidelines, NICE advice and quality standards ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results